Multibaggers of 2022: These pharmaceutical stocks more than doubled the wealth of investors! Do you own them?
Multibaggers of 2022: These pharmaceutical stocks more than doubled the wealth of investors! Do you own them?

Multibaggers of 2022: These pharmaceutical stocks more than doubled the wealth of investors! Do you own them?

After a prolonged correction, the index underwent another surge in recent times as healthcare stocks gained momentum due to the deteriorating Covid scenario.

Mandar Wagh Article rating: 5.0

After a prolonged correction, the index underwent another surge in recent times as healthcare stocks gained momentum due to the deteriorating Covid scenario. 

Advent International buys more than 50 per cent stake for Rs 6300 crore in this pharma company. Do you own it?
Advent International buys more than 50 per cent stake for Rs 6300 crore in this pharma company. Do you own it?

Advent International buys more than 50 per cent stake for Rs 6300 crore in this pharma company. Do you own it?

Advent is expected to buy 51 per cent of the promoter’s stake in the company and launch an open offer for an additional 26 per cent

Bhavya Rathod Article rating: 4.3

The company released a press release on Monday, stating Advent International has entered into definitive agreement to acquire significant stake in the company and intends to explore the merger of  its portfolio company

Stocks below Rs 100: Only buyers seen in these scrips on October 3
Stocks below Rs 100: Only buyers seen in these scrips on October 3

Stocks below Rs 100: Only buyers seen in these scrips on October 3

The FIIs sold equity worth Rs 1,565.31 crore on Friday (September 30) while the DIIs bought equity for a net worth of Rs 3,245.45 crore.    

Sayali Kotwal Article rating: 3.8

At the time of market closing on Monday, the headline equity indices, i.e. Sensex and Nifty 50 plunged over a per cent each, owing to the rising inflation fears in the US markets.  

Stocks below Rs 100: Only buyers seen in these scrips on September 23
Stocks below Rs 100: Only buyers seen in these scrips on September 23

Stocks below Rs 100: Only buyers seen in these scrips on September 23

The FIIs sold equity worth Rs 2,409.55 crore on Thursday (September 22) while the DIIs bought equity for a net worth of Rs 263.07 crore

Sayali Kotwal Article rating: 4.1

At 11.30 am on Friday, the headline equity indices, i.e. Sensex and Nifty 50 are seen extending their losing streak in the morning, owing to weak global cues.  

Top-performing pharma stocks in July 2022
Top-performing pharma stocks in July 2022

Top-performing pharma stocks in July 2022

The pharmaceutical sector in India ranks third in terms of volume and fourteenth in terms of value (both globally).  

Sayali Kotwal Article rating: 3.7

The pharmaceutical sector in India ranks third in terms of volume and fourteenth in terms of value (both globally).  The domestic market is anticipated to increase three times in the next ten years, according to the Indian Economic Survey 2021.

 

These pharma stocks gained up to 79.74 per cent in just one month!
These pharma stocks gained up to 79.74 per cent in just one month!

These pharma stocks gained up to 79.74 per cent in just one month!

List of top 15 pharma stocks that have outperformed the markets in the past one month.

Shreya Chaware Article rating: 4.2

In Q4FY22, the financial performance of the pharma companies was affected by the rising raw material & freight costs. Despite the pressure on margins, some pharmaceutical companies managed to showcase decent financial performance in Q4FY22. 

Pharma stocks outperform; Dr Reddys Laboratories emerges as top BSE Sensex gainer
Pharma stocks outperform; Dr Reddys Laboratories emerges as top BSE Sensex gainer

Pharma stocks outperform; Dr Reddys Laboratories emerges as top BSE Sensex gainer

On the sectoral front, indices traded with modest gains with the pharma sector outperforming

Shreya Chaware Article rating: 5.0

In the first hour of the trading session, Sensex and Nifty were able to recover some of the opening losses and traded flat. At the time of market opening, 27 out of 30 stocks on Sensex were trading in the red. The top gainers on Sensex are Dr Reddy’s Laboratories, Reliance Industries, and Maruti Suzuki whereas the top losers include Asian Paints, Tata Steel, Power Grid Corporation, L&T, and UltraTech Cement.  

High momentum stock: Aurobindo Pharma Ltd
High momentum stock: Aurobindo Pharma Ltd

High momentum stock: Aurobindo Pharma Ltd

With the ongoing bullishness, the stock is expected to perform well in the near future. 

Rohit Kale Article rating: 3.8

The stock of Aurobindo Pharma is extremely bullish today and has surged nearly 2 per cent despite turmoil in the market.

Shilpa Biologicals join hands with Mylab to enter in vaccine and personalised therapeutics business
Shilpa Biologicals join hands with Mylab to enter in vaccine and personalised therapeutics business

Shilpa Biologicals join hands with Mylab to enter in vaccine and personalised therapeutics business

Shilpa Biologicals Pvt Ltd, a subsidiary of Shilpa Medicare Ltd, has announced a strategic tie-up with Mylab Discovery Solutions, India’s leading diagnostic solutions provider.

Sayali Kotwal Article rating: 5.0

Shilpa Biologicals Pvt Ltd, a subsidiary of Shilpa Medicare Ltd, has announced a strategic tie-up with Mylab Discovery Solutions, India’s leading diagnostic solutions provider. With this association, Shilpa Medicare expects to venture into the vaccine and therapeutics segment

DSIJ MINDSHARE

Mkt Commentary2-Jun, 2023

Mindshare2-Jun, 2023

Mindshare2-Jun, 2023

Mindshare2-Jun, 2023

Mindshare2-Jun, 2023

Knowledge

General2-Jun, 2023

Fundamental28-May, 2023

Fundamental17-May, 2023

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Investment in securities market are subject to market risks.Read all the related documents carefully before investing.
Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.